About National Centre for Infectious Diseases (NCID)
The National Centre for Infectious Diseases, previously known as the Communicable Disease Centre, is a national public health institute under the Ministry of Health of Singapore.
There are 330 (500 during outbreaks) beds in National Centre for Infectious Diseases (NCID).
Clinical Trials at National Centre for Infectious Diseases (NCID)
During the past decade, National Centre for Infectious Diseases (NCID) conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "National Centre for Infectious Diseases (NCID)"
#1 collaborator was "A*Star" with 2 trials as a collaborator, "Duke-NUS Graduate Medical School" with 1 trials as a collaborator, "KK Women's and Children's Hospital" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "World Health Organization Collaborating Centre for Reference and Research on Influenza (WHOCCRRI)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at National Centre for Infectious Diseases (NCID)
According to Clinical.Site data, the most researched conditions in "National Centre for Infectious Diseases (NCID)" are
"COVID-19" (5 trials) and "Influenza Vaccination" (1 trials). Many other conditions were trialed in "National Centre for Infectious Diseases (NCID)" in a lesser frequency.
Clinical Trials Intervention Types at National Centre for Infectious Diseases (NCID)
Most popular intervention types in "National Centre for Infectious Diseases (NCID)" are "Drug" (4 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Remdesivir" (4 trials), "Baricitinib" (2 trials), "Dexamethasone" (1 trials) and "Fluarix Quadrivalent vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at National Centre for Infectious Diseases (NCID)
The vast majority of trials in "National Centre for Infectious Diseases (NCID)" are
6 trials for "All" genders.
Clinical Trials Status at National Centre for Infectious Diseases (NCID)
Currently, there are NaN active trials in "National Centre for Infectious Diseases (NCID)".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in National Centre for Infectious Diseases (NCID),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Centre for Infectious Diseases (NCID), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".